COVID-19 virtual patient cohort reveals immune mechanisms driving disease outcomes

Adrianne L. Jenner; Rosemary A. Aogo; Sofia Alfonso; Vivienne Crowe; Amanda P. Smith; Penelope A. Morel; Courtney L. Davis; Amber M. Smith; Morgan Craig.
Preprint en Inglés | PREPRINT-BIORXIV | ID: ppbiorxiv-425420

Documentos relacionados

  1. COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes.
  2. COVID-19 virtual patient cohort reveals immune mechanisms driving disease outcomes.
  3. Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.
  4. The T cell immune response against SARS-CoV-2.
  5. In silico dynamics of COVID-19 phenotypes for optimizing clinical management.
  6. COV2Var, a function annotation database of SARS-CoV-2 genetic variation.
  7. Mass cytometry reveals a conserved immune trajectory of recovery in hospitalized COVID-19 patients.
  8. Myeloid dysregulation and therapeutic intervention in COVID-19.
  9. A patient-centric modeling framework captures recovery from SARS-CoV-2 infection.
  10. Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab.